Active ingredientPhentermine HydrochlorideCat. No. P-P088-001CAS 1197-21-3Family · Pharmaceutical analytical standards
Phentermine
An appetite suppressant that stimulates the release of noradrenaline and dopamine in the brain, reducing appetite; approved in the United States in 1959 for the short-term treatment of obesity, alongside diet and exercise, and since 2012 also in combination with topiramate. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its name is a contraction of its chemical description, phenyl-tertiary-butylamine: a phenyl ring attached to a tert-butylamine group.
Go to the active ingredient →Active ingredientPhentermine HydrochlorideCat. No. P-P088-001CAS 1197-21-3
Isotopically labelledPhentermine-d5 HydrochlorideCat. No. P-P088-002CAS 1330236-21-9
Isotopically labelledPhentermine-d6Cat. No. P-P088-003CAS 1261734-85-3
ImpurityN-Hydroxy PhentermineCat. No. P-P088-004CAS 38473-30-2
ImpurityPhentermine PhenethylamineCat. No. P-P088-005CAS 5531-33-9
ImpurityPhentermine Related Compound ACat. No. P-P088-006CAS 52117-13-2
ImpurityPhentermine Related Compound CCat. No. P-P088-007CAS 768-49-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.